Immucell Corporation Revenue per Employee (ICCC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Immucell Corporation  (NASDAQ: ICCC)
 

Immucell's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 11.5% in the second quarter 2026, year on year to cumulative value of $30 million, Immucell's revenue per employee grew on a trailing twelve months basis to $ 407,900, this marks a new company high.
Within the Healthcare sector Employees of 243 other companies have achieved higher revenue per employee. While Immucell's total ranking has deteriorated compared to the previous quarter from 1803 to 1989. Immucell has 73 employees.


What is Sales per Employee Ratio?







ICCC Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 11.5 % 19.71 % -15.47 % -10.79 % 23.22 %
Sales per Employee (TTM) $ 407,900 397,746 375,962 394,944 403,827
ICCC's Total Ranking # 1989 # 1803 # 1944 # 1204 # 1238
Seq. Revenue Change -25.59 % 27.57 % 41.15 % -16.79 % -20.11 %


Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 244
Overall Market # 1989

Revenue per Employee Statistics
High Average Low
$ 407,900 $ 197,839 $ 80,396
(Jun 30 2026)   (Sep 30 2013)



Financial Statements
Immucell's Revenue MRQ $ 7 Millions Visit ICCC's Income Statement
Immucell's Revenues TTM $ 30 Millions Visit ICCC's aggregate revenue growth
What are ICCC's Sales? Visit ICCC's Sales by Segment




Other Ratios
Immucell's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ICCC's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ICCC's Competitors
Revenue per Employee for ICCC's Suppliers
Revenue per Employee for ICCC's Customers

You may also want to know
ICCC's Sales Growth Rates ICCC's Pe Price to earnings ratio ICCC's Receivables Turnover Ratio ICCC's Stock Quote
ICCC's Net Income Growth Rates ICCC's Ps Price to Sales ratio ICCC's Sales per Employee ICCC's Asset Turnover Ratio
ICCC's Net Margin ICCC's Pb Price to Book ratio ICCC's Financial Strength Ratios ICCC's Dividend Payout Ratio
Date modified: 2026-09-03T11:51:49+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Sunshine Biopharma Inc   706,935.44 $ 35.347  Million 50 
Johnson and Johnson  695,518.47 $ 97,929.000  Million 140,800 
Intuitive Surgical Inc   663,668.41 $ 11,296.300  Million 17,021 
Biolife Solutions Inc   662,696.77 $ 102.718  Million 155 
Premier Air Charter Holdings Inc   644,120.78 $ 31.562  Million 49 
Karyopharm Therapeutics Inc   643,074.56 $ 146.621  Million 228 
Evofem Biosciences Inc   622,241.38 $ 18.045  Million 29 
Nexgel Inc   621,578.95 $ 11.810  Million 19 
Organon and Co   613,900.00 $ 6,139.000  Million 10,000 
Nature s Sunshine Products inc   610,161.29 $ 491.790  Million 806 
Nephros Inc   602,388.89 $ 21.686  Million 36 
Jaguar Health Inc   591,808.51 $ 27.815  Million 47 
Milestone Scientific Inc   590,317.47 $ 8.855  Million 15 
Waters Corporation  587,879.62 $ 4,644.249  Million 7,900 
Phibro Animal Health Corporation  582,288.29 $ 1,516.861  Million 2,605 
Rhythm Pharmaceuticals Inc   579,512.08 $ 239.918  Million 414 
Macrogenics Inc   572,266.21 $ 167.674  Million 293 
Cardiff Lexington Corporation  567,380.00 $ 10.213  Million 18 
Embecta Corp   551,189.19 $ 1,019.700  Million 1,850 
Iridex Corp  548,860.22 $ 51.044  Million 93 
Henry Schein Inc   544,080.00 $ 13,602.000  Million 25,000 
Enanta Pharmaceuticals Inc  543,816.67 $ 65.258  Million 120 
Instil Bio Inc   527,529.41 $ 8.968  Million 17 
Globus Medical Inc   524,155.67 $ 3,144.934  Million 6,000 
10x Genomics Inc   523,400.68 $ 616.566  Million 1,178 
Iradimed Corporation  520,114.23 $ 86.339  Million 166 
Alpha Pro Tech Ltd   505,723.58 $ 62.204  Million 123 
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.